The Endometrial Microbiome & IVF Outcomes: Testing for Repeated Implantation Failure

The endometrial microbiome may affect IVF implantation success. For people facing repeated implantation failure with no clear cause found on standard work-ups, the endometrial microbiome has emerged as a promising area of reproductive research.

This article breaks down 2026 new research findings on the endometrial microbiome, how it may affect IVF success rates, and what these studies mean for your treatment decisions.

The Uterus Is Not Sterile

In the past, the medical community believed the uterine cavity was completely sterile. This view shifted after 2015 with advances in genetic sequencing, which identified a low-abundance but detectable microbial community inside the uterus.

Lactobacillus is the most widely studied genus in this field.

In a healthy female reproductive tract, lactobacilli produce lactic acid to maintain an acidic local environment. This keeps overgrowth of unwanted bacteria in check and supports a stable setting for embryo implantation.

When lactobacilli drop and other bacteria (including potential pathogens) multiply, this is called dysbiosis. New 2026 studies are exploring how this imbalance connects with IVF treatment results.

Key 2026 Research Insights

Pathogens in the Endometrium May Lower Live-Birth Odds

A retrospective case-control study published in October 2026 reviewed uterine microbiome data from 595 fertility patients.

Among egg-donor cycles, patients with detectable pathogenic bacteria had a 25% live-birth rate, compared with 49.2% for patients with no identified pathogens.

The key finding is straightforward. IVF outcomes depend more on whether dangerous pathogens are present, rather than the amount of beneficial lactobacilli.

Lactobacilli may not directly trigger implantation. Instead, their main role appears to be suppressing pathogens and maintaining local stability. 

Even with lactobacilli present, outcomes suffer if pathogens exist. On the other hand, when no pathogens are detected, high lactobacilli levels do not bring extra live-birth advantages.

Lactobacilli Species Matter More Than Raw Quantity

Another study of 257 IVF patients looked at endometrial microbiome testing results. Traditionally, lactobacilli dominance (over 90%) has been viewed as favourable. However, not every Lactobacillus species delivers the same benefit.

For example, L. crispatus and L. gasseri tend to correlate with better reproductive performance. By contrast, pregnancy rates tend to fall when L. iners accounts for more than 74.2% of your uterine bacteria.

A report marked “lactobacilli-dominant” does not tell the whole story. It matters which specific Lactobacillus species you carry.

Microbiome Imbalance Can Sometimes Be Improved With Treatment

In this same study, patients with insufficient lactobacilli levels received antibiotics or targeted therapy.

Patients whose follow-up tests showed restored microbial balance achieved pregnancy rates comparable to patients who started with favourable lactobacilli dominance.

While the microbiome may be modifiable to some degree, there remains a gap between “possible to improve” and “recommended for everyone as standard care”.

Important Limitations of Current Evidence

In June 2026, the Science Committee of the UK’s Human Fertilisation and Embryology Authority (HFEA) released a formal review.

It concluded that microbiome-reproductive outcome evidence remains largely experimental. There is limited global consensus on clinically relevant microbial profiles, and insufficient support to recommend routine testing or treatment.

Major unanswered questions include:

1. Who should be screened: Should testing be offered to all IVF patients, or only those with repeated implantation failure (RIF) / recurrent miscarriage?

2. How to standardise testing: Different laboratories use varied assays and reporting formats, making cross-lab result comparisons unreliable.

3. Do interventions truly raise live-birth rates? Some studies show pregnancy-rate improvements after antibiotics or probiotics, but overall evidence strength is still low for routine clinical use.

What This Means for You

Consider testing for unexplained RIF

If you have repeated implantation failure with no cause found on standard testing, you may talk to your fertility doctor about endometrial microbiome testing.

Still, it remains exploratory and is not a routine check before embryo transfer for everyone.

Review species, not just lactobacilli percentage

If you complete endometrial microbiome testing, pay attention to individual Lactobacillus species listed in your report.

A high proportion of L. iners needs separate consideration, even when overall lactobacilli percentages look good.

Do not take probiotics on your own

Some studies suggest probiotics may help, but results are mixed. There is not enough reliable evidence to support using them on your own. Always consult your fertility provider before starting any supplements.

Implantation depends on many factors

Embryo quality, endometrial receptivity, hormone status and immune factors all influence implantation success. The endometrial microbiome is just one active area of research, not the sole deciding factor.

Final Thoughts

New research published in 2026 moves the endometrial microbiome from a vague theoretical concept toward something testable, discussable and sometimes modifiable. Even so, it stays at the research frontier and is not yet a mature, routine clinical tool.

For couples navigating repeated implantation failure, the value of this topic is not to demand immediate testing or treatment. It helps you understand what directions science is exploring when standard evaluations cannot give answers, and that is meaningful preparation for your fertility journey.

To learn more about evaluation options for repeated implantation failure, email info@cefivf.com or visit our Contact page.

Disclaimer: This article draws on peer-reviewed 2026 studies and the HFEA Science Committee review. It serves educational purposes only and does not constitute medical advice. All assessments and treatment plans should follow personalised clinical judgement from your fertility specialist.